查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193436

軟骨發育不全的全球市場和COVID-19影響分析:各類型，診斷，各終端用戶，各地區 - 產業分析，市場規模，市場佔有率，預測(2023年～2030年)

Achondrogenesis Market with COVID-19 Impact Analysis, By Type, By Diagnosis, End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

全球軟骨發育不全的市場規模在2022年估算為18億710萬美金，在2023年～2030年間預計將以年複合成長率4.4％的速度成長。

本報告提供全球軟骨發育不全市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 軟骨發育不全市場概要

第2章 摘要整理

  • 市場明細
    • 各類型
    • 診斷
    • 各終端用戶
    • 各國
    • 各地區
  • 競爭考察

第3章 軟骨發育不全的主要的市場趨勢

  • 推動市場要素
    • 推動市場要素的影響分析
  • 阻礙市場要素
    • 阻礙市場要素的影響分析
  • 市場機會
  • 市場未來趨勢

第4章 軟骨發育不全的產業調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法律規範分析

第5章 軟骨發育不全市場:COVID-19影響分析

  • COVID-19以前的影響分析
  • COVID-19以後的影響分析

第6章 軟骨發育不全市場展望

  • 市場佔有率分析(2023年)
  • 明細資料:各主要製造商
    • 現有企業的分析
    • 新興企業的分析

第7章 軟骨發育不全市場:各類型

  • 概要

第8章 軟骨發育不全市場:診斷

  • 概要

第9章 軟骨發育不全市場:各終端用戶

  • 概要

第10章 軟骨發育不全市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區(APAC)
  • 南美
  • 中東·非洲

第11章 主要供應商分析

  • 競爭儀表板
  • 企業簡介
    • Thermo Fisher Scientific Inc.
    • CooperSurgical, Inc.
    • Illumina, Inc
    • Siemens
    • FUJIFILM Holdings Corporation
    • Koninklijke Philips N.V.
    • Stryker
    • TOSHIBA CORPORATION
    • Invivoscribe, Inc.
    • Abbott
    • INVITROGEN CORPORATION
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Natera Inc.
    • Cepheid
    • ELITech Group
    • Autogenomics,
    • F. Hoffmann-La Roche AG

第12章 分析師全方位展望

第13章 附錄

Product Code: ANV1064

REPORT HIGHLIGHT

Achondrogenesis Market size was valued at USD 1,807.1 Million in 2022, expanding at a CAGR of 4.4% from 2023 to 2030.

Achondrogenesis is defined by the excessive shortening of the legs and arms in comparison to the trunk as a result of faulty rib, vertebra, and other skeletal anomalies in growth and development. Infants are typically affected by chondrogenesis, which frequently causes them to pass away before birth.

Market Dynamics

The prevalence of hereditary genes, which includes achondrogenesis among others, is rising globally, and as a result, the market is anticipated to experience significant growth over the forecast period. Achondrogenesis is defined by the excessive shortening of the legs and arms in comparison to the trunk as a result of faulty rib, vertebra, and other skeletal anomalies in growth and development. Flat face, anteverted nares, frontal bossing, fatal skeletal dysplasia, and aberrant endochondral ossification are only a few of the illness signs linked to chondrogenesis. According to the NORD (National Organization for Rare Disease), achondrogenesis affects one in 40,000-60,000 newborns.

Additionally, the market is growing as a result of rising research efforts and the high reliance of patients on supportive and palliative care. Additionally, growing healthcare costs and technology developments for disease diagnostics present potential prospects for the industry. However, the Achondrogenesis market may be hampered by factors such as a lack of effective treatment options, high illness detection costs, and a shortage of qualified specialists. Because hereditary illnesses are becoming more common and governments are becoming more concerned about the health of newborns, Asia-Pacific is predicted to hold the biggest market share.

Segmentation Analysis:

The Global Achondrogenesis Market is segmented on the basis of Type, Diagnosis, End User, and Region.

The market is split into three categories based on Type: Type IA, Type IB, and Type II. The Type IA segment dominates the market. Various symptoms associated with achondrogenesis includes flat face, anteverted nares, which is mainly contributing to segment growth.

The market is segmented into four categories based on Diagnosis: physical examination, molecular genetic testing, and biochemical testing. The genetic testing segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the number of genetic disorders across the globe.

The market is segmented into five categories based on End User: clinics, hospitals, diagnostic centers, academic research, and others. The diagnostic centers segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the clinical diagnostic activities, boosting the segment growth.

Competitive Landscape:

The worldwide market for Achondrogenesis is highly fragmented in nature which consist of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new research projects, partnerships, distribution network development, R&D spending, and mergers and acquisitions.

For instance, in November 2022, Illumina Inc., and Genetic Alliance introduced $120 Million global initiative to increase equity and improve outcomes for families impacted by genetic disease.

Key features of the study:

This proposed research study on Achondrogenesis market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Achondrogenesis market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Achondrogenesis market

Impact of COVID-19 on Achondrogenesis market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Achondrogenesis market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Achondrogenesis market, we have also included competitive landscape and key innovator analysis for the Achondrogenesis market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Achondrogenesis market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global Achondrogenesis market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ACHONDROGENESIS MARKET KEY PLAYERS

Thermo Fisher Scientific Inc.

CooperSurgical, Inc.

Illumina, Inc

Siemens

FUJIFILM Holdings Corporation

Koninklijke Philips N.V.

Stryker

TOSHIBA CORPORATION

Invivoscribe, Inc.

Abbott

INVITROGEN CORPORATION

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Natera Inc.

Cepheid

ELITech Group

Autogenomics,

F. Hoffmann-La Roche AG

GLOBAL ACHONDROGENESIS MARKET, BY TYPE

Type IA

Type IB

Type II

GLOBAL ACHONDROGENESIS MARKET, BY DIAGNOSIS

Physical examination

Molecular genetic testing

Biochemical testing

GLOBAL ACHONDROGENESIS MARKET, BY END USER

Clinics

Hospitals

Diagnostic Centers

Academic Research

Others

GLOBAL ACHONDROGENESIS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. Achondrogenesis Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by Diagnosis
    • 2.1.3. Market Snippet by End User
    • 2.1.4. Market Snippet by Country
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. Achondrogenesis Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Achondrogenesis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Achondrogenesis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Achondrogenesis Market Landscape

  • 6.1. Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Achondrogenesis Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2030 (%)
    • 7.1.2. Type IA
    • 7.1.3. Type IB
    • 7.1.4. Type II

8. Achondrogenesis Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2030 (%)
    • 8.1.2. Physical examination
    • 8.1.3. Molecular genetic testing
    • 8.1.4. Biochemical testing

9. Achondrogenesis Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2030 (%)
    • 9.1.2. Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Academic Research
    • 9.1.6. Others

10. Achondrogenesis Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. CooperSurgical, Inc.
    • 11.2.3. Illumina, Inc
    • 11.2.4. Siemens
    • 11.2.5. FUJIFILM Holdings Corporation
    • 11.2.6. Koninklijke Philips N.V.
    • 11.2.7. Stryker
    • 11.2.8. TOSHIBA CORPORATION
    • 11.2.9. Invivoscribe, Inc.
    • 11.2.10. Abbott
    • 11.2.11. INVITROGEN CORPORATION
    • 11.2.12. Bio-Rad Laboratories, Inc.
    • 11.2.13. Agilent Technologies, Inc.
    • 11.2.14. Natera Inc.
    • 11.2.15. Cepheid
    • 11.2.16. ELITech Group
    • 11.2.17. Autogenomics,
    • 11.2.18. F. Hoffmann-La Roche AG

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Achondrogenesis Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Achondrogenesis Market, by Type 2018-2030 (USD Million)
  • TABLE Achondrogenesis Market: Diagnosis Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnosis
  • TABLE Global Achondrogenesis Market, by Diagnosis 2018-2030 (USD Million)
  • TABLE Achondrogenesis Market: Regional snapshot (2023)
  • TABLE Achondrogenesis Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Achondrogenesis Market, by End User 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Achondrogenesis Market, by Region 2018-2030 (USD Million)
  • TABLE North America Achondrogenesis Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Achondrogenesis Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Achondrogenesis Market, by Diagnosis, 2018-2030 (USD Million)
  • TABLE North America Achondrogenesis Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Achondrogenesis Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Achondrogenesis Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Achondrogenesis Market, by Diagnosis, 2018-2030 (USD Million)
  • TABLE Europe Achondrogenesis Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Achondrogenesis Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Achondrogenesis Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Achondrogenesis Market, by Diagnosis, 2018-2030 (USD Million)
  • TABLE Asia Pacific Achondrogenesis Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Achondrogenesis Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Achondrogenesis Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Achondrogenesis Market, by Diagnosis, 2018-2030 (USD Million)
  • TABLE Latin America Achondrogenesis Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Achondrogenesis Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Achondrogenesis Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Achondrogenesis Market, by Diagnosis, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Achondrogenesis Market, by End User, 2018-2030 (USD Million)